Zobrazeno 1 - 10
of 45
pro vyhledávání: '"structum"'
Publikováno v:
Паёми Сино, Vol 23, Iss 4, Pp 520-531 (2021)
Objective: To study and comparatively evaluate the clinical and cost-effectiveness of modern structure/disease modifying anti- osteoarthritis drugs (S/ DMOADs) and hyaluronic acid (HLA) in modern intensive treatment of the primary knee osteoarthritis
Externí odkaz:
https://doaj.org/article/15194d09854748e3b02b959fe2e69bb0
Autor:
E. V. Mazukina, E. V. Shekunova, V. M. Kosman, I. N. Urakova, I. G. Kotelnikova, M. Yu. Fonarev, E. A. Ezhova, E. V. Zakalyukina, M. N. Makarova, V. G. Makarov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 9, Iss 1, Pp 43-57 (2021)
Chondroitin sulfate is used for osteoarthritis combination therapy. It should be taken into account that the structure and properties of polysaccharides included in chondroitin sulfate, as well as the raw materials used for its production, have a sig
Externí odkaz:
https://doaj.org/article/b7be5f7448054084aa1d9cdc323162a1
Autor:
O A Shavlovskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 5, Pp 98-104 (2017)
Chondroprotectors (CP) are biological agents that contribute to the regeneration of the cartilage surfaces and articular capsule, participating in the metabolic processes of the articular cartilage. Progressive loss of hyaline cartilage and lower lev
Externí odkaz:
https://doaj.org/article/73a4aad1ea134ccb9592a171a5deddd8
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 42, Iss 3, Pp 153-158 (2015)
Background Chondroitin sulfate (CS) is a major component of the extracellular matrix of many connective tissues, including cartilage, bone, skin, ligaments, and tendons. Objective The aim of this work was to study the effect of CS treatment for short
Externí odkaz:
https://doaj.org/article/ca4102f0ffbe49c8b6ba1322e2dd7a3b
Autor:
V I Mazurov, I B Belyaeva
Publikováno v:
Терапевтический архив, Vol 79, Iss 8, Pp 68-71 (2004)
Aim. To assess duration of a clinical response and tolerance ofstructum in patients with low back pain (LBP) and comorbid cardiovascular disease. Material and methods. 25 patients with primary LBP and coronary heart disease (n = 13) and/or essential
Externí odkaz:
https://doaj.org/article/1fb36207a4f94491b96091e5d2e94af0
Autor:
L I Alekseeva, G S Arkhangelskaya, A F Davydova, E A Karmiltseva, К М Kogan, V I Mazurov, A P Rebrov, O F Ryabitseva, T G Shemerovskaya, S S Yakushin, V A Nasonova, D G Soldatov
Publikováno v:
Терапевтический архив, Vol 78, Iss 9, Pp 82-86 (2003)
Aim. To evaluate duration of a clinical response to the drug structum in patients with osteoarthrosis (OA) of the knee and hip joints as well as structum effects on OA course and that of concomitant diseases. Material and methods. The duration of a c
Externí odkaz:
https://doaj.org/article/f2dd9ee88dcc4eefbba4757b56c5423e
Autor:
V A Nassonova, L I Alexeyeva, G S Arkhangelskaya, A. F. Davydova, E A Karmiltzeva, K M Kogan, V I Mazurov, A P Rebrov, O F Ryabitzeva, T G Shemerovskaya, S. S. Yakushin
Publikováno v:
Научно-практическая ревматология, Vol 39, Iss 2, Pp 46-51 (2001)
Objective. Study of the efficacy and tolerability of Structum in pts with gonarthritis and coxarthritis during 6 months therapy. Material. Open multicentral study included off -patients of both sexes with osteoarthritis (ОЛ) of knee and hip joints
Externí odkaz:
https://doaj.org/article/ac8ed7fdc18144a698a8d53d5a4766c9
Publikováno v:
Терапевтический архив, Vol 79, Iss 11, Pp 93-95 (2004)
Aim. To study efficacy of the chondroprotector chondroitin sulphate (structum, Pier Fabr Medicament Production, France) in patients with rheumatoid arthritis (RA) and secondary osteoarthrosis of the knee joints. Material and methods. 15 women with a
Externí odkaz:
https://doaj.org/article/26ed4dbfca94481db5436ad602b16e76
Publikováno v:
Научно-практическая ревматология, Vol 41, Iss 1, Pp 40-42 (2003)
Objective. To assess Structum (chondroitin sulfate) efficacy in treatment of osteoarthritis in Republic of Karelia. Methods. 34 pts with osteoarthritis (mean disease duration 6,44±0,67 years) were included. Functional Leken score (FLS), pain at rest
Externí odkaz:
https://doaj.org/article/c4c24f79b6b7408fb3165ca386daad1e
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 42, Iss 3, Pp 153-158 (2015)
Background Chondroitin sulfate (CS) is a major component of the extracellular matrix of many connective tissues, including cartilage, bone, skin, ligaments, and tendons. Objective The aim of this work was to study the effect of CS treatment for short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a2ec3182c03a85105999dc1b51cec9b
http://www.err.eg.net/article.asp?issn=1110-161X
http://www.err.eg.net/article.asp?issn=1110-161X